The techniques and knowledge in molecular biology are advancing rapidly. The basic mechanisms involved in the pathogenesis of various lung conditions including asthma, COPD and lung cancer are being clarified by the application of this powerful technology. Genetic causes of single gene disorders such as cystic fibrosis and alpha-1 antitrypsin deficiency have now been well delineated. This progress leads to an understanding of the pathogenic process that result in disease. The purpose of Volumes I and II of "Molecular Biology of the Lung" is to provide an update on the use of this powerful technology. As such, the books provide an insight into the techniques for the non-specialist. Scientists embarking upon studies in chronic lung disease will find a review of the current status of research. At the same time, the books are useful to clinicians, both specialist and academic, and to scientists already involved in the basic aspects of the pathogenesis of lung disease. Both volumes deal with basic mechanisms of cell biology, receptors and cell activation and provides an insight as to how the technology influences our concepts of pathogenesis and vice versa.

Volume editor: David Raeburn, M. A. Giembycz